PEN logo

Penumbra (PEN) Company Overview

Profile

Full Name:

Penumbra, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

September 18, 2015

Indexes:

Not included

Website:

http://www.penumbrainc.com

Description:

Penumbra, Inc. is a medical company focused on innovative treatment methods, which designs, develops, manufactures, and sells medical devices. The company's products are aimed at two main segments: vascular diseases and neurosurgery. In both of these markets, the company offers key products: thrombectomy systems - for removing blood clots (thrombi) and embolization systems - for treating patients with various sizes of aneurysms and other vascular and nervous disorders. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.

Key Details

Price

$281.62

Market Cap

$10.85 B(Large cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$1.19 B(+12.86% YoY)

Annual EPS

$0.36(-84.48% YoY)

PE Ratio

828.29

Annual ROE

1.20%

Annual Debt To Equity

0.00

Beta

0.58

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Feb 18, 2025

Recent annual earnings:

Feb 18, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 16, 2014

Analyst ratings

Recent major analysts updates

Feb 19, 25 Wells Fargo
Overweight
Feb 19, 25 UBS
Buy
Feb 19, 25 Truist Securities
Buy
Feb 19, 25 RBC Capital
Outperform
Feb 19, 25 Piper Sandler
Overweight
Feb 19, 25 Needham
Hold
Feb 19, 25 Morgan Stanley
Equal-Weight
Feb 19, 25 JP Morgan
Overweight
Feb 19, 25 Canaccord Genuity
Buy
Feb 19, 25 Baird
Outperform

Screeners with PEN included

US stocks
High Piotroski score stocks
Most recommended stocks
Best performing stocks last 3 months
Best performing stocks last 5 years
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
High Altman Z score stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$281.62
PEN price is $281.62

Price All-time High

$344.06
PEN price is currently -18.15% below its historical high of $344.06

Price Analysts Target

$311.50
PEN price is currently -9.59% lower than the consensus analysts' forecast

Price Today Change

-2.11%
PEN price is down -2.11% today

Price YTD Change

+20.92%
PEN price is up +20.92% since January 1st

Price 3-Year Change

+26.33%
PEN price is up +26.33% over the past 3 years

Market cap

Market Cap

$10.85 B
PEN market capitalization is $10.85 billion

Market Cap 3-Year Change

+29.23%
PEN market capitalization is up +29.23% over the past 3 years

Market Cap All-time High

$13.21 B
PEN market capitalization is currently -17.91% below its historical high of $13.21 billion

Market Cap Sector Rank

92.6%
PEN market capitalization is higher than 92.6% of companies in Healthcare sector

Technical

Beta

0.58
PEN beta is 0.58

200-day SMA

$215.69
PEN price is currently +30.57% above its 200-day simple moving average

14-day RSI

56.50
PEN 14-day relative strength index is 56.50

30-day Relative Volume

0.95
PEN 30-day relative volume is 0.95

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$1.19 B
PEN annual revenue is $1.19 billion

Annual Revenue Analysts Estimate

$1.35 B
PEN annual revenue is currently -11.67% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+12.86%
PEN annual revenue is up +12.86% year-on-year

Annual Revenue Sector Rank

82.48%
PEN annual revenue is higher than 82.48% of companies in Healthcare sector

Profit

Annual Gross Profit

$755.00 M
PEN annual gross profit is $755.00 million

Annual Gross Margin

63.20%
PEN annual gross profit margin is 63.20%

Annual Operating Profit

$86.22 M
PEN annual operating income is $86.22 million

Annual Operating Margin

7.22%
PEN annual operating profit margin is 7.22%

Annual Net Income

$14.01 M
PEN annual net profit is $14.01 million

Annual Net Margin

1.17%
PEN annual net profit margin is 1.17%

EPS

Annual EPS

$0.36
PEN annual earnings per share is $0.36

Annual EPS Analysts Estimate

$3.66
PEN annual earnings per share is currently -90.17% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-84.48%
PEN annual earnings per share is down -84.48% year-on-year

Annual EPS Sector Rank

86.61%
PEN annual earnings per share is higher than 86.61% of companies in Healthcare sector

ROA & ROE

Annual ROA

0.91%
PEN annual return on assets is 0.91%

Annual ROE

1.20%
PEN annual return on equity is 1.20%

EBIT & EBITDA

Annual EBIT

$22.29 M
PEN annual earnings before interest & taxes is $22.29 million

Annual EBITDA

$45.99 M
PEN annual EBITDA is $45.99 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

828.29
PEN price to earnings ratio is 828.29

PE Ratio Sector Rank

99.49%
PEN price to earnings ratio is higher than 99.49% of companies in Healthcare sector

PB Ratio

PB Ratio

9.42
PEN price to book ratio is 9.42

PB Ratio Sector Rank

90.82%
PEN price to book ratio is higher than 90.82% of companies in Healthcare sector

PS Ratio

PS Ratio

9.08
PEN price to sales ratio is 9.08

PS Ratio Sector Rank

75.06%
PEN price to sales ratio is higher than 75.06% of companies in Healthcare sector

Enterprise value

Enterprise Value

$10.75 B
PEN enterprise value is $10.75 billion

Enterprise Value Sector Rank

92.86%
PEN enterprise value is higher than 92.86% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

249.54
PEN EV/EBITDA is 249.54

EV/EBITDA Sector Rank

99.12%
PEN EV/EBITDA is higher than 99.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

6.01
PEN annual current ratio is 6.01

Annual Quick Ratio

3.44
PEN annual quick ratio is 3.44

Leverage

Annual Debt To Equity

0.00
PEN annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

15.72
PEN annual interest coverage ratio is 15.72

Risk & Stability

Piotroski F-Score

8
PEN piotroski f-score is 8

Altman Z-Score

18.53
PEN altman z-score is 18.53

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$1.53 B
PEN annual total assets is $1.53 billion

Annual Non Current Assets

$582.06 M
PEN annual long term assets is $582.06 million

Annual Current Assets

$951.13 M
PEN annual total current assets is $951.13 million

Annual Cash & Cash Equivalents

$324.40 M
PEN annual cash & cash equivalents is $324.40 million

Equity

Annual Book Value

$1.15 B
PEN annual book value is $1.15 billion

Annual Working Capital

$792.78 M
PEN annual working capital is $792.78 million

Liabilities

Annual Total Liabilities

$382.25 M
PEN annual total liabilities is $382.25 million

Annual Total Long Term Liabilities

$223.91 M
PEN annual total long term liabilities is $223.91 million

Annual Current Liabilities

$158.34 M
PEN annual total current liabilities is $158.34 million

Annual Accounts Payable

$31.33 M
PEN annual accounts payable is $31.33 million

Debt

Annual Total Debt

$223.39 M
PEN annual total debt is $223.39 million

Annual Total Debt 1-Year Change

-4.67%
PEN annual total debt is down -4.67% year-on-year

Annual Long Term Debt

$208.80 M
PEN annual long term debt is $208.80 million

Annual Short Term Debt

$14.59 M
PEN annual short term debt is $14.59 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$1.11 B
PEN annual total expenses is $1.11 billion

Annual Operating Expenses

$668.77 M
PEN annual total operating expenses is $668.77 million

Annual Cost Of Goods Sold

$439.62 M
PEN annual cost of goods sold is $439.62 million

Annual SGA

$573.99 M
PEN annual SGA is $573.99 million

Annual D&A

$23.70 M
PEN annual depreciation & amortization is $23.70 million

Annual Interest Expense

$1.42 M
PEN annual interest expense is $1.42 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$168.48 M
PEN annual cash flow from operations is $168.48 million

Annual CFO 1-Year Change

+73.1%
PEN annual cash flow from operations is up +73.1% year-on-year

Annual CFI

$77.62 M
PEN annual cash flow from investing activities is $77.62 million

Annual CFI 1-Year Change

+582.86%
PEN annual cash flow from investing activities is up +582.86% year-on-year

Annual CFF

-$87.01 M
PEN annual cash flow from financing activities is -$87.01 million

Annual CFF 1-Year Change

-636.97%
PEN annual cash flow from financing activities is down -636.97% year-on-year

Free CashFlow

Annual FCF

$147.30 M
PEN annual free cash flow is $147.30 million

Annual FCF 1-Year Change

+79.37%
PEN annual free cash flow is up +79.37% year-on-year

CAPEX

Annual CAPEX

$21.18 M
PEN annual capital expenditures is $21.18 million

Annual CAPEX 1-Year Change

+39.24%
PEN annual capital expenditures is up +39.24% year-on-year

Institutional Ownership

Similar stocks

GMED logo
Globus Medical (GMED)
RDY logo
Dr Reddys Laboratories Limited (RDY)
COR logo
Cencora (COR)
MEDP logo
Medpace Holdings (MEDP)
EXEL logo
Exelixis (EXEL)
DVA logo
DaVita (DVA)
SRPT logo
Sarepta Therapeutics (SRPT)
TECH logo
Bio-Techne (TECH)
EHC logo
Encompass Health (EHC)

FAQ

  • What is the ticker symbol for Penumbra?
  • Does Penumbra pay dividends?
  • What sector is Penumbra in?
  • What industry is Penumbra in?
  • What country is Penumbra based in?
  • When did Penumbra go public?
  • Is Penumbra in the S&P 500?
  • Is Penumbra in the NASDAQ 100?
  • Is Penumbra in the Dow Jones?
  • When was Penumbra's last earnings report?
  • When does Penumbra report earnings?
  • Should I buy Penumbra stock now?

What is the ticker symbol for Penumbra?

The ticker symbol for Penumbra is NYSE:PEN

Does Penumbra pay dividends?

No, Penumbra does not pay dividends

What sector is Penumbra in?

Penumbra is in the Healthcare sector

What industry is Penumbra in?

Penumbra is in the Medical Devices industry

What country is Penumbra based in?

Penumbra is headquartered in United States

When did Penumbra go public?

Penumbra's initial public offering (IPO) was on September 18, 2015

Is Penumbra in the S&P 500?

No, Penumbra is not included in the S&P 500 index

Is Penumbra in the NASDAQ 100?

No, Penumbra is not included in the NASDAQ 100 index

Is Penumbra in the Dow Jones?

No, Penumbra is not included in the Dow Jones index

When was Penumbra's last earnings report?

Penumbra's most recent earnings report was on Feb 18, 2025

When does Penumbra report earnings?

The next expected earnings date for Penumbra is May 7, 2025

Should I buy Penumbra stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions